Back
Tema GLP-1, Obesity & Cardiometabolic ETF 10K Form
Sell
17
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
Last Price:
$29.73
Seasonality Move:
12.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HRTS News And Ratings
See the #1 stock for the next 7 days that we like better than HRTS
HRTS Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Tema GLP-1, Obesity & Cardiometabolic ETF Earnings Forecast
Key Tema GLP-1, Obesity & Cardiometabolic ETF Financial Ratios
Tema GLP-1, Obesity & Cardiometabolic ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | HRTS |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
HRTS Technical Analysis vs Fundamental Analysis
Sell
17
Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS)
is a Sell
Is Tema GLP-1, Obesity & Cardiometabolic ETF a Buy or a Sell?
-
Tema GLP-1, Obesity & Cardiometabolic ETF stock is rated a SellThe current Tema GLP-1, Obesity & Cardiometabolic ETF [HRTS] share price is $29.64. The Score for HRTS is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.